RegeneronREGN
Regeneron on podcasts: where it advertises, what it's offering listeners, and what hosts say about it when they're not being paid.
Sponsorships
No ad reads on tracked podcasts in the last 30 days. Hosts are talking about it anyway — see the earned side.
What hosts are saying
Most mentioned on
In their words
“um so, I utilize Repatha, and I kind of forget some of the other stuff I'm on, but I I was on rosuvastatin, but I I switched over to like ezetimibe... without the drug Repatha which is a P-PCSK9 inhibitor.”
The host discusses using Repatha (a Regeneron product) as part of their medical treatment for high cholesterol, mentioned in a factual medical context without praise or criticism.
▶ Hear it“Speaker names Regeneron as a company 'very heavily invested in treasuries' that are 'very cashrich and they will over the long run probably benefit from what we're seeing right now.'”
Speaker highlighted it as a cash-rich company heavily invested in treasuries that will likely benefit from high yields.
▶ Hear it“partnership with a USlisted firm uh Regeneron Pharmaceuticals. This is to co-develop and co-com commercialize four new drugs. So these are antibbody drugs for diseases related to the immune system. The two companies have collaborated uh before.”
Company announced expanded partnership with Sanofi to co-develop and co-commercialize four new antibody drugs for immune system diseases.
▶ Hear itThe full picture
A weekly email with where each one advertised and what hosts said about them. Free.